The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
Open accessAbstract
Interleukin 15 (IL-15) controls both the homeostasis and the peripheral activation of natural killer (NK) cells. The molecular basis for this duality of action remains unknown. Here we found that the metabolic checkpoint kinase mTOR was activated and boosted bioenergetic metabolism after exposure of NK cells to high concentrations of IL-15, whereas low doses of IL-15 triggered only phosphorylation of the transcription factor STAT5. mTOR stimulated the growth and nutrient uptake of NK cells and positively fed back on the receptor for IL-15. This process was essential for sustaining NK cell proliferation during development and the acquisition of cytolytic potential during inflammation or viral infection. The mTORC1 inhibitor rapamycin inhibited NK cell cytotoxicity both in mice and humans; this probably contributes to the immunosuppressive activity of this drug in different clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Self-citationInnate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389
Self-citationPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
Metabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692
mTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
A unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation
Lodolce, J. P., Boone, D. L., Chai, S., Swain, R. E., Dassopoulos, T., Trettin, S., & Ma, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80664-0 · Cited by 1,299
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Satoh-Takayama, N., Vosshenrich, C. A. J., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.-J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.001 · Cited by 1,095
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,082
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
Magnuson, B., Ekim, B., & Fingar, D. C. (2012) · Biochemical Journal · doi:10.1042/bj20110892 · Cited by 1,015
Sanos, S. L., Bui, V. L., Mortha, A., Oberle, K., Heners, C., Johner, C., & Diefenbach, A. (2009) · Nature Immunology · doi:10.1038/ni.1684 · Cited by 847
Maturation of mouse NK cells is a 4-stage developmental program
Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E., & Walzer, T. (2009) · Blood · doi:10.1182/blood-2008-10-187179 · Cited by 787
Self-citationCD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity
Hayakawa, Y., & Smyth, M. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1517 · Cited by 749
The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturation
Gordon, S. M., Chaix, J., Rupp, L. J., Wu, J., Madera, S., Sun, J. C., Lindsten, T., & Reiner, S. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.016 · Cited by 731
mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s
Frias, M. A., Thoreen, C. C., Jaffe, J. D., Schroder, W., Sculley, T., Carr, S. A., & Sabatini, D. M. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.001 · Cited by 695
In vivo developmental stages in murine natural killer cell maturation
Kim, S., Iizuka, K., Kang, H.-S. P., Dokun, A., French, A. R., Greco, S., & Yokoyama, W. M. (2002) · Nature Immunology · doi:10.1038/ni796 · Cited by 610
Nguyen, K. B., Salazar-Mather, T. P., Dalod, M. Y., Van Deusen, J. B., Wei, X.-Q., Liew, F. Y., Caligiuri, M. A., Durbin, J. E., & Biron, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4279 · Cited by 610
Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596
Luci, C., Reynders, A., Ivanov, I. I., Cognet, C., Chiche, L., Chasson, L., Hardwigsen, J., Anguiano, E., Banchereau, J., Chaussabel, D., et al. (2009) · Nature Immunology · doi:10.1038/ni.1681 · Cited by 554
Self-citationSpecific and nonspecific NK cell activation during virus infection
Dokun, A. O., Kim, S., Smith, H. R. C., Kang, H.-S. P., Chu, D. T., & Yokoyama, W. M. (2001) · Nature Immunology · doi:10.1038/ni714 · Cited by 477
Metabolic checkpoints in activated T cells
Wang, R., & Green, D. R. (2012) · Nature Immunology · doi:10.1038/ni.2386 · Cited by 464
Lee, K., Gudapati, P., Dragovic, S., Spencer, C., Joyce, S., Killeen, N., Magnuson, M. A., & Boothby, M. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.002 · Cited by 464
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells
Cooper, M. A., Bush, J. E., Fehniger, T. A., VanDeusen, J. B., Waite, R. E., Liu, Y., Aguila, H. L., & Caligiuri, M. A. (2002) · Blood · doi:10.1182/blood-2001-12-0293 · Cited by 455
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
García-Martínez, J. M., Moran, J., Clarke, R. G., Gray, A., Cosulich, S. C., Chresta, C. M., & Alessi, D. R. (2009) · Biochemical Journal · doi:10.1042/bj20090489 · Cited by 455
Fehniger, T. A., Cai, S. F., Cao, X., Bredemeyer, A. J., Presti, R. M., French, A. R., & Ley, T. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.010 · Cited by 451
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
Walzer, T., Chiossone, L., Chaix, J., Calver, A., Carozzo, C., Garrigue-Antar, L., Jacques, Y., Baratin, M., Tomasello, E., & Vivier, E. (2007) · Nature Immunology · doi:10.1038/ni1523 · Cited by 431
Self-citationPhosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking
Sinclair, L. V., Finlay, D., Feijoo, C., Cornish, G. H., Gray, A., Ager, A., Okkenhaug, K., Hagenbeek, T. J., Spits, H., & Cantrell, D. A. (2008) · Nature Immunology · doi:10.1038/ni.1603 · Cited by 390
Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy
Risson, V., Mazelin, L., Roceri, M., Sanchez, H., Moncollin, V., Corneloup, C., Richard-Bulteau, H., Vignaud, A., Baas, D., Defour, A., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200903131 · Cited by 381
Self-citationFate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor
Narni-Mancinelli, E., Chaix, J., Fenis, A., Kerdiles, Y. M., Yessaad, N., Reynders, A., Gregoire, C., Luche, H., Ugolini, S., Tomasello, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112064108 · Cited by 360
Self-citationVosshenrich, C. A. J., Ranson, T., Samson, S. I., Corcuff, E., Colucci, F., Rosmaraki, E. E., & Di Santo, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1213 · Cited by 283
Mortier, E., Advincula, R., Kim, L., Chmura, S., Barrera, J., Reizis, B., Malynn, B. A., & Ma, A. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.017 · Cited by 235
Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival
Hand, T. W., Cui, W., Jung, Y. W., Sefik, E., Joshi, N. S., Chandele, A., Liu, Y., & Kaech, S. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003457107 · Cited by 228
A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development
Eckelhart, E., Warsch, W., Zebedin, E., Simma, O., Stoiber, D., Kolbe, T., Rülicke, T., Mueller, M., Casanova, E., & Sexl, V. (2011) · Blood · doi:10.1182/blood-2010-06-291633 · Cited by 222
Regulation of Mouse NK Cell Development and Function by Cytokines
Marçais, A., Viel, S., Grau, M., Henry, T., Marvel, J., & Walzer, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00450 · Cited by 178
Self-citationSignal Transduction During Activation and Inhibition of Natural Killer Cells
Watzl, C., & Long, E. O. (2010) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109bs90 · Cited by 165
Salmond, R. J., Emery, J., Okkenhaug, K., & Zamoyska, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902294 · Cited by 133
Tassi, I., Cella, M., Gilfillan, S., Turnbull, I. R., Diacovo, T. G., Penninger, J. M., & Colonna, M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.014 · Cited by 118
Baranek, T., Manh, T. V., Alexandre, Y. O., Maqbool, M. A., Cabeza, J. Z., Tomasello, E., Crozat, K., Bessou, G., Zucchini, N., Robbins, S. H., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.002 · Cited by 116
Guo, H., Samarakoon, A., Vanhaesebroeck, B., & Malarkannan, S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072327 · Cited by 107
Kim, N., Saudemont, A., Webb, L. M. C., Camps, M., Rückle, T., Hirsch, E., Turner, M., & Colucci, F. (2007) · Blood · doi:10.1182/blood-2007-02-075366 · Cited by 95
Cutting Edge: IL-15-Independent NK Cell Response to Mouse Cytomegalovirus Infection
Sun, J. C.-Y., Ma, A., & Lanier, L. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901872 · Cited by 93
NK Cell Maturation and Function in C57BL/6 Mice Are Altered by Caloric Restriction
Clinthorne, J. F., Beli, E., Duriancik, D. M., & Gardner, E. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201837 · Cited by 64
Different NK Cell Developmental Events Require Different Levels of IL-15 Trans-Presentation
Lee, G. A., Liou, Y.-H., Wang, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100331 · Cited by 45
Orr, S. J., Roessler, S., Quigley, L., Chan, T., Ford, J. W., O’Connor, G. M., & McVicar, D. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903528 · Cited by 15
Cited by
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,066
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Bader, J. E., Voss, K., & Rathmell, J. C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.034 · Cited by 1,030
Regulation of innate immune cell function by mTOR
Weichhart, T., Hengstschläger, M., & Linke, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3901 · Cited by 830
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01124 · Cited by 825
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Viel, S., Marçais, A., Guimaraes, F. S.-F., Loftus, R., Rabilloud, J., Grau, M., Degouve, S., Djebali, S., Sanlaville, A., Charrier, E., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad1884 · Cited by 672
Self-citation
Metadata
- Authors
- Marçais, A., Cherfils-Vicini, J., Viant, C., Degouve, S., Viel, S., Fenis, A., Rabilloud, J., Mayol, K., Tavares, A., Bienvenu, J., Gangloff, Y.-G., Gilson, E., Vivier, E., & Walzer, T.
- Venue
- Nature Immunology
- Published
- 2014-06-29
- Volume
- 15
- Issue
- 8
- Pages
- 749-757
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2104825199
- Cited by
- 614
- References
- 49
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.